Biktarvy, formally known as bictegravir sulfate, represents a effective single-tablet therapy for controlling HIV infection. This drug combines three key antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It functions by blocking the virus's ability to multiply within the body, significantly decreasing the viral load. Fo